- This topic is empty.
-
Posts
-
-
This page lists the main topics and stocks discussed on Mad Money with Jim Cramer aired on November 21, 2025, with links to CNBC articles, videos, and English transcripts.
2025年11月21日放送の 「Mad Money with Jim Cramer」 で取り上げられた主な話題・銘柄を、CNBCの記事・動画・英文トランスクリプトへのリンクとともに一覧化しています。
(1) Cramer’s week ahead: Earnings from Burlington, Best Buy, Kohl’s and Dell (https://www.cnbc.com/2025/11/21/cramers-week-ahead-earnings-from-burlington-best-buy-kohls-and-dell.html)
- CNBC’s Jim Cramer on Friday walked investors through next week on Wall Street.
- He highlighted earnings reports from a number of major retailers as well as tech giant Dell.
- “Every data point, every bit of research and earnings will be scrutinized starting Monday, just like a regular week, even as we’ll be eating turkey and then relaxing, with everyone watching the Philadelphia Eagles play the Bears at home on Amazon,” he said.
(2) As the market fluctuates, Jim Cramer names three lower risk stocks with high dividends (https://www.cnbc.com/2025/11/21/jim-cramer-three-lower-risk-stocks-high-dividends.html)
- After a volatile week on Wall Street, CNBC’s Jim Cramer explained why he thinks Enbridge, Pfizer and Realty Income can yield solid returns.
- “There are a lot of high yielders that are dangerous — their yields soar because investors don’t believe the company can keep covering the cost of the dividend,” Cramer said. “But these three are not like that, and I regard them as very, very safe.”
Ticker: ENB, PFE, O
(3) [No Video Clip for non-Club members] Oddity’s fundamentals remain great, pullback is a good buying opportunity, says Jim Cramer (https://www.cnbc.com/video/2025/11/21/odditys-fundamentals-remain-great-pullback-is-a-good-buying-opportunity-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer looks at digital-first beauty and wellness brand Oddity.
Ticker: ODD
(4) [No Video Clip for non-Club members] Executive Interview: AstraZeneca CEO Pascal Soriot goes one-on-one with Jim Cramer (https://www.cnbc.com/video/2025/11/21/astrazeneca-ceo-pascal-soriot-goes-one-on-one-with-jim-cramer.html)
AstraZeneca CEO Pascal Soriot joins ‘Mad Money’ host Jim Cramer to talk manufacturing expansion, growth plans, next-gen therapies, and more
Ticker: AZN
(5) Cramer’s Lighting Round: POET Technologies is ‘losing too much money’ (https://www.cnbc.com/2025/11/21/cramers-lighting-round-poet-technologies-is-losing-too-much-money.html)
- Mettler Toledo: ”[buy, buy, buy!] You’ve got a good one there.”
- Opendoor: “The stock is high given the fact that the company makes no money. I’m not a believer until it makes money.”
- POET Technologies: “It’s losing too much money…I can’t recommend the stock.”
Ticker: MTD, OPEN, PTK
(6) [No Video Clip for non-Club members] What led the market down Thursday was Micron and Sandisk, says Jim Cramer (https://www.cnbc.com/video/2025/11/21/what-led-the-market-down-thursday-was-micron-and-sandisk-says-jim-cramer.html)
‘Mad Money’ host Jim Cramer talks if the market sell-off has bottomed yet.
Other Stocks Discussed (calls with audience)/ この日の放送で取り上げられたその他の銘柄（視聴者からの電話):
Ref: Links related to this episode /参考: この日の放送に関するその他のサイトへのリンク
- Podcast at Spotify (Sound /音声）
- InternetArchive（Video & Texts per minute /1分毎のビデオ＆テキスト）
****************************
Previous Episode/ 前回のエピソード Next Episode / 次回のエピソード
-
- The forum ‘Mad Money Stock Archive (ジム・クレイマーの銘柄紹介)’ is closed to new topics and replies.